Regulatory
Regulatory strategy and TGA approval pathways in Australia.
Adelis Health manages regulatory strategy, submissions and approval pathways so healthcare innovations can reach the Australian market and maintain ongoing compliance.
What We Deliver
Approval is a commercial milestone, not a paperwork exercise.
Regulatory requirements shape how a product is developed, what evidence it needs and how quickly it can reach patients. Adelis plans the regulatory pathway alongside clinical and commercial work so approval and market entry progress together.
Capabilities
Regulatory support from strategy to post-approval.
The capabilities required to define an approval pathway, submit a credible application and maintain compliance once a product is on the market.
Regulatory Strategy
Defining the approval pathway for a product early, so development, evidence generation and commercial planning are aligned with the requirements that determine market access.
TGA Submissions
Preparing and managing submissions to the Therapeutic Goods Administration, including dossier assembly, classification, evidence packaging and responses to regulator questions.
Classification & Evidence Requirements
Establishing how a product is classified and what clinical, technical and quality evidence is required to support its approval and intended claims.
Quality & Compliance Systems
Implementing the quality management, documentation and manufacturing compliance frameworks that regulators expect to see supporting an application.
Post-Approval Obligations
Maintaining ongoing compliance after approval, including variations, reporting obligations, labelling and vigilance requirements.
Where We Apply It
Regulatory pathways across healthcare innovation.
Pharmaceuticals
Medical Devices
Diagnostics
Digital Health Products
Clinical & Regulatory Together
Evidence built for the pathway it has to satisfy.
Regulatory outcomes depend on the quality and relevance of clinical evidence. Adelis designs clinical programs with the approval requirements already in view, reducing rework and avoidable delay.
Explore clinical development- Pathway defined before evidence is generated
- Submissions aligned with TGA expectations
- Quality systems built alongside development
- Compliance maintained after approval
Planning an Australian approval?
Whether you need a regulatory strategy, submission support or an integrated development and commercialisation partner, we would like to understand your product.
Talk to Adelis